These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20155945)

  • 1. Biotransformation of plant secondary metabolite decursin by Mycobacterium sp. PYR1001.
    Kim KY; Lee S; Cha CJ
    J Agric Food Chem; 2010 Mar; 58(5):2931-4. PubMed ID: 20155945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decursinol angelate: a cytotoxic and protein kinase C activating agent from the root of Angelica gigas.
    Ahn KS; Sim WS; Lee IK; Seu YB; Kim IH
    Planta Med; 1997 Aug; 63(4):360-1. PubMed ID: 9270380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Angelica gigas Nakai on the production of decursin- and decursinol angelate-enriched eggs.
    Fontamillas GAD; Kim SW; Kim HU; Kim SJ; Kim JG; Park TS; Park BC
    J Sci Food Agric; 2019 Apr; 99(6):3117-3123. PubMed ID: 30536922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.
    Li L; Zhang J; Xing C; Kim SH; Lü J
    Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decursin and decursinol angelate selectively inhibit NADH-fumarate reductase of Ascaris suum.
    Shiomi K; Hatano H; Morimoto H; Ui H; Sakamoto K; Kita K; Tomoda H; Lee EW; Heo TR; Kawagishi H; Omura S
    Planta Med; 2007 Nov; 73(14):1478-81. PubMed ID: 17948169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase.
    Son SH; Kim MJ; Chung WY; Son JA; Kim YS; Kim YC; Kang SS; Lee SK; Park KK
    Cancer Lett; 2009 Jul; 280(1):86-92. PubMed ID: 19307054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity.
    Kang SY; Kim YC
    J Pharm Pharmacol; 2007 Jun; 59(6):863-70. PubMed ID: 17637179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 Isoforms in the Metabolism of Decursin and Decursinol Angelate from Korean Angelica.
    Zhang J; Li L; Tang S; Hale TW; Xing C; Jiang C; Lü J
    Am J Chin Med; 2015; 43(6):1211-30. PubMed ID: 26394652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceutical characterization of decursin and their derivatives for drug discovery.
    Mahat B; Chae JW; Baek IH; Song GY; Song JS; Ma JY; Kwon KI
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1523-30. PubMed ID: 23003006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-pass metabolism of decursin, a bioactive compound of Angelica gigas, in rats.
    Park HS; Kim B; Oh JH; Kim YC; Lee YJ
    Planta Med; 2012 Jun; 78(9):909-13. PubMed ID: 22573368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas.
    Ahn KS; Sim WS; Kim IH
    Planta Med; 1996 Feb; 62(1):7-9. PubMed ID: 8720379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
    Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
    Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
    Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
    Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.
    Li L; Zhang J; Shaik AA; Zhang Y; Wang L; Xing C; Kim SH; Lü J
    Planta Med; 2012 Feb; 78(3):252-9. PubMed ID: 22116603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of beta-catenin.
    Song GY; Lee JH; Cho M; Park BS; Kim DE; Oh S
    Mol Pharmacol; 2007 Dec; 72(6):1599-606. PubMed ID: 17855653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of pyranocoumarin isomers decursin and decursinol angelate by liver microsomes from man and rodents.
    Li L; Zhang J; Xing C; Kim SH; Jiang C; Lü J
    Planta Med; 2013 Nov; 79(16):1536-44. PubMed ID: 24026903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of phenylalanine ammonia-lyase and cinnamate 4-hydroxylase and pyranocoumarin biosynthesis in Angelica gigas.
    Park JH; Park NI; Xu H; Park SU
    J Nat Prod; 2010 Aug; 73(8):1394-7. PubMed ID: 20701298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
    Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
    Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Determination of Decursin, Decursinol Angelate, Nodakenin, and Decursinol of
    Kim SJ; Ko SM; Choi EJ; Ham SH; Kwon YD; Lee YB; Cho HY
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29701699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.